Translating Advances in Multiomic Profiling to Effective Oncology Care for Pediatric Brain Tumors

Pediatric neuro-oncology represents a rapidly evolving field challenged by the biological complexity and rarity of childhood brain tumors. Recent advances in molecular characterization, enabled by high-throughput multiomic profiling, have transformed our understanding of tumor heterogeneity and disease mechanisms. While these insights have illuminated distinct biological tumor subtypes and their drivers, children with high-grade brain tumors continue to face poor prognoses and stagnant survival outcomes. Persistent gaps remain due to small patient numbers, limited opportunities for large randomized trials, and the slow translation of molecular findings into routine clinical care. Current debates focus on the clinical integration of multiomic data and the search for frameworks that can transform these molecular advances into actionable therapies.Emerging research has redefined pediatric brain tumor classification by linking unique genomic, transcriptomic, and proteomic profiles to clinical behavior and treatment response. These discoveries have highlighted potential therapeutic vulnerabilities and fostered the development of precision medicine strategies. Innovative classification schemes and adaptive clinical trial designs are beginning to shift therapeutic paradigms. However, obstacles remain in ethically and logistically implementing individualized therapies for a rare and diverse patient population. Despite these challenges, harnessing multiomic diagnostics to personalize care holds immense promise, and ongoing studies underscore the need for consensus on optimal integration of omics-driven strategies into clinical practice.This Research Topic aims to accelerate the clinical translation of multiomic and precision medicine advances in pediatric brain tumors by consolidating interdisciplinary efforts. The objective is to bridge omics-based discoveries and real-world patient care, highlight barriers to clinical application, and showcase innovative clinical trial models and case studies demonstrating the impact of personalized therapy. Submissions that critically evaluate molecularly informed patient stratification, targeted therapy selection, biomarker development, and the implementation of adaptive and N-of-1 trial frameworks are especially encouraged. The aim is to foster a robust dialogue on how unique molecular features can inform practical, evidence-based improvements in pediatric neuro-oncology.This Research Topic is focused on bridging multiomic science with clinical care in pediatric brain tumors, emphasizing advances, challenges, and strategies at their intersection. The scope excludes unrelated areas of pediatric oncology outside the central nervous system and research lacking a clinical translation angle.To gather further insights within this focused area, we welcome articles addressing, but not limited to, the following themes:- Integration and interpretation of genomic, transcriptomic, and proteomic data for personalized therapy.- Molecular subtyping and its role in risk stratification and treatment decision-making.- Case studies employing precision or N-of-1 methodologies in pediatric brain tumor care.- Biomarker discovery and validation for disease monitoring and therapeutic response.- Overcoming clinical and ethical barriers in the adoption of multiomic diagnostics.- Design and outcomes of novel clinical trial paradigms in rare pediatric cancers.Please note that manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases that are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of the scope of this Research Topic.Dr. Van Meter has declared they are the Chief Scientific Officer of BRAINBox Solutions, Inc. He also provides outside scientific consulting through Outside Science Consulting, LLC. Topic editors: Timothy E Van Meter,PhD, Kimberly Hoang Source: https://www.frontiersin.org/research-topics/86039/translating-advances-in-multiomic-profiling-to-effective-oncology-care-for-pediatric-brain-tumors